« Previous
Next »
Ultrasound in Medicine and Biology
Volume 33, Issue 1
, Pages 15-25
, January 2007
Transcranial brain parenchyma sonography in movement disorders: State of the art
References
- Copper genes are not implicated in the pathogenesis of focal dystonia. Neurology. 2002;59:782–783
- . Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov Disord. 2001;16:23–32
- . Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res. 1994;55:75–84
- . Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology. 1995;45:182–184
- Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry. 1995;38:180–184
- Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry. 1997;63:590–596
- Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord. 1997;12:79–88
- Increased tissue copper and manganese content of the lentiform nucleus in primary adult-onset dystonia. Ann Neurol. 1999;46:260–263
- . Evidence for disturbances of copper metabolism in dystonia (From the image towards a new concept). Neurology. 2001;57:2290–2294
- Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse. Mov Disord. 2002;17:710;––716
- . Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry. 2005;76:423–425
- Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology. 1999;53:1026–1031
- Depression in Parkinson‘s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol. 1999;246:1186–1193
- Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol. 1999;25:901–904
- The basal ganglia in haemochromatosis. Neuroradiology. 2000;42:9–13
- Differences of echogenicity and T2 relaxation time of the nucleus lentiformis in MSA and PSP as compared to Parkinson’s disease. Mov Disord. 2000;15(Suppl 3):206–207
- Changes of copper transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol. 2000;47:827–830
- . Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology. 2001;56:13–17
- . Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry. 2001;50:463–467
- . Echogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings. J Neurol. 2001;8:684–689
- Echogenicity of the substantia nigra: Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol. 2002;59:999–1005
- . Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease. Mov Disord. 2005;20:383–385
- . Sonographic examination of the adult brain. J Clin Ultrasound. 1988;16:337–345
- . Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol. 1992;32(Suppl):S94–S100
- . Impaired iron homeostasis in Parkinson’s disease. J Neural Transm. 2000;60(Suppl):37–58
- Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features. Ann Neurol. 1996;39:490–499
- . Ageing and Parkinson’s disease: Substantia nigra regional selectivity. Brain. 1991;114:2283–2301
- Screening for mutations of the ferritin light and heavy genes in Parkinson’s disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett. 2003;352:53–56
- . New evolution of transcranial tomography (TCT) and transcranial color Doppler tomography (TCDT). Neurosonology. 1989;1:8–15
- Huntingtin: An iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet. 2000;9:2789–2797
- Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004;63:1912–1917
- Postnatal decrease in substantia nigra echogenicity (Implications for the pathogenesis of Parkinson’s disease). J Neurol. 2004;251:1451–1454
- . Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum (A preliminary transcranial ultrasound study). Neuropsychobiology. 2001;44:183–186
- . Two-dimensional echoencephalography with electronic sector scanning (Clinical experiences with a new method). J Neurol Neurosurg Psychiatry. 1972;35:912–918
- Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra. Mov Disord. 2005;20:258–260
- Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia. Ann Neurol. 2001;49:405–408
- . Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology. 1996;47:1284–1290
- Brain parenchyma sonography in patients with essential tremor and Parkinson′s disease. Cerebrovasc Dis. 2004;17(Suppl 4):3
- Basal ganglia alterations and brain atrophy in Huntington’s disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry. 1999;67:457–462
- Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm. 2004;68(Suppl):123–133
- Transcranial sonography of the brain parenchyma: comparison of B-mode imaging and tissue harmonic imaging. Ultrasound Med Biol. 2000;26:189–194
- Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson’s disease. NeuroImage. 2003;18:416–422
- . Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging. 1995;5:105–108
- Detection of presymptomatic Parkinson’s disease: Combining smell tests, transcranial sonography, and SPECT. Mov Disord. 2004;19:1196–1202
- . Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson’s disease. J Neural Transm. 2002;109:191–196
- Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes. Neurology. 2003;60:74–77
- Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology. 2004;63:504–509
- Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord. 2004;19:1445–1449
- Sonographic detection of basal ganglia abnormalities in asymptomatic and symptomatic Wilson disease. Neurology. 2005;64:1726–1732
PII: S0301-5629(06)01749-2
doi: 10.1016/j.ultrasmedbio.2006.07.021
© 2006 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Ultrasound in Medicine and Biology
Volume 33, Issue 1
, Pages 15-25
, January 2007
